EUVIMED · CrossrefJournal
Onco
ISSN 2673-7523 · MDPI AG
Latest articles
Antigen-Processing Machinery in Clear-Cell Renal Cell Carcinoma: RNA-Adjusted Protein Abundance Across Histologic Grade
Alternative Splicing as a Prognostic Determinant in Colorectal Cancer: An Integrated Multi-Omics Analysis
Robot-Assisted Single-Port PSMA-Radioguided Surgery for Isolated Seminal Vesicle Recurrence of Prostate Cancer After Multimodal Therapy
In Silico Characterization of FABP5-Associated Candidate Genes in Prostate Cancer Progression
Identification of Candidate Biomarkers in Oral Cancer Using Integrated Bioinformatics Analysis: An Insight from Liquid Biopsy Approach
Melanoma During Pregnancy: Clinical Outcomes, Therapeutic Decision-Making, and Ethical–Medico-Legal Challenges—A Systematic Review
Implementation of Recent WHO Classification in Publications on Glioblastoma Research Using Multi-Omics Databases
Prognostic Value of Gleason Score for Overall Survival in Prostate Cancer: A Population-Based SEER Cohort Study
Nanotechnology-Driven Epigenetic Targeting: Tailoring Ovarian Cancer Therapeutics
Epigenetic Reprogramming in Cancer Metastasis: From Histone Modifications to Therapeutic Vulnerabilities
Cancer Therapy-Related Cutaneous Toxicities: Prognostic Biomarkers, Immunologic Endotypes, and Novel Therapeutic Strategies
Primary Renal Neuroendocrine Tumor in a Horseshoe Kidney: A Case Report of an Indolent Course
Rethinking Immunotherapy Drug Development in Head and Neck Squamous Cell Carcinoma: The Role of Biologic Context and Treatment Sequencing
Transformation of NSCLC to SCLC: Insights into Molecular Alterations, Tumor Origin, and Therapeutic Advancements
Reflex Sanger Sequencing Reveals a Rare UGT1A1 *28/*37 Compound Heterozygous Genotype After an Indeterminate Commercial Result in Late-Line Gastric Cancer
Antipsychotics for Cancer Treatment: Current Evidence
The Gut–Nutrient–Genome Axis: A Host-Integrated Perspective on Genomic Instability in Cancer
Correction: Das et al. Development of a Murine Intracranial Surgical Resection Glioblastoma Model to Facilitate Preclinical In Vivo Drug Screening. Onco 2026, 6, 24
Advances in Diagnostic, Prognostic and Predictive Biomarker Testing for the Characterization of Uterine Mesenchymal Neoplasms
A Pilot Retrospective Evaluation of Colpofix® Ovules for the Management of Radiation-Induced Vaginal Toxicity in Patients with Mid-Low Rectal and Anal Cancers
Tumor Immune Infiltration and Its Association with Immune-Active Tumor Phenotypes in Muscle-Invasive Bladder Cancer: An Integrative TCGA Analysis
Colorectal Cancer Stem Cells: Mechanisms of Resistance and Emerging Therapeutic Targeting Strategies
Intercellular Mitochondrial Trafficking as a Master Regulator of Tumor Progression and Cancer Stem Cell Plasticity
Development of a Murine Intracranial Surgical Resection Glioblastoma Model to Facilitate Preclinical In Vivo Drug Screening
Macrophage Activation Syndrome Following Atezolizumab in Advanced Non-Small-Cell Lung Cancer: A Case Report
Hub Gene Clusters Reveal Dysregulated Synaptic Neurotransmitter Signaling Pathways and Drug Repurposing Prospect in Brain Tumors
The Emerging Role of MicroRNAs in Oral Cancer: From Pathogenesis to Targeted Therapy
Established and Emerging Less Invasive Biomarkers and Technologies for Lung Cancer Screening: Puerto Rican Context
Integrating DNA Methylation Profiling into Pediatric Brain Tumor Diagnostics: Insights from Four Cases
The Male Predominance in HBV-Related Hepatocellular Carcinoma: Unraveling the Axis of Androgen Receptor, Viral Replication, and Immune Evasion via NKG2D Ligands
EUVIMED